Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1996 2
1997 2
1998 1
1999 2
2000 1
2003 1
2004 3
2005 1
2007 1
2008 1
2009 1
2010 1
2011 4
2012 6
2013 3
2014 7
2015 6
2016 5
2017 4
2018 12
2019 10
2020 16
2021 6
2022 4
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Results by year

Filters applied: . Clear all
Page 1
Non-classical ferroptosis inhibition by a small molecule targeting PHB2.
Yang W, Mu B, You J, Tian C, Bin H, Xu Z, Zhang L, Ma R, Wu M, Zhang G, Huang C, Li L, Shao Z, Dai L, Désaubry L, Yang S. Yang W, et al. Among authors: desaubry l. Nat Commun. 2022 Dec 3;13(1):7473. doi: 10.1038/s41467-022-35294-2. Nat Commun. 2022. PMID: 36463308 Free PMC article.
Updates in Anthracycline-Mediated Cardiotoxicity.
Nebigil CG, Désaubry L. Nebigil CG, et al. Among authors: desaubry l. Front Pharmacol. 2018 Nov 12;9:1262. doi: 10.3389/fphar.2018.01262. eCollection 2018. Front Pharmacol. 2018. PMID: 30483123 Free PMC article. Review.
Emergence of cardio-oncology.
Nebigil CG, Désaubry L. Nebigil CG, et al. Among authors: desaubry l. Ann Pharm Fr. 2018 Nov;76(6):504-506. doi: 10.1016/j.pharma.2018.06.003. Epub 2018 Jul 31. Ann Pharm Fr. 2018. PMID: 30075937
Therapeutic Potential of Targeting Prokineticin Receptors in Diseases.
Vincenzi M, Kremić A, Jouve A, Lattanzi R, Miele R, Benharouga M, Alfaidy N, Migrenne-Li S, Kanthasamy AG, Porcionatto M, Ferrara N, Tetko IV, Désaubry L, Nebigil CG. Vincenzi M, et al. Among authors: desaubry l. Pharmacol Rev. 2023 Nov;75(6):1167-1199. doi: 10.1124/pharmrev.122.000801. Epub 2023 Sep 8. Pharmacol Rev. 2023. PMID: 37684054 Free PMC article. Review.
Inhibition of MYC translation through targeting of the newly identified PHB-eIF4F complex as a therapeutic strategy in CLL.
Largeot A, Klapp V, Viry E, Gonder S, Fernandez Botana I, Blomme A, Benzarti M, Pierson S, Duculty C, Marttila P, Wierz M, Gargiulo E, Pagano G, An N, El Hachem N, Perez Hernandez D, Chakraborty S, Ysebaert L, François JH, Cortez Clemente S, Berchem G, Efremov DG, Dittmar G, Szpakowska M, Chevigné A, Nazarov PV, Helleday T, Close P, Meiser J, Stamatopoulos B, Désaubry L, Paggetti J, Moussay E. Largeot A, et al. Among authors: desaubry l. Blood. 2023 Jun 29;141(26):3166-3183. doi: 10.1182/blood.2022017839. Blood. 2023. PMID: 37084385 Free PMC article.
SFPH proteins as therapeutic targets for a myriad of diseases.
Wang D, Tabti R, Elderwish S, Djehal A, Chouha N, Pinot F, Yu P, Nebigil CG, Désaubry L. Wang D, et al. Among authors: desaubry l. Bioorg Med Chem Lett. 2020 Nov 15;30(22):127600. doi: 10.1016/j.bmcl.2020.127600. Epub 2020 Oct 6. Bioorg Med Chem Lett. 2020. PMID: 33035678 Free PMC article. Review.
97 results